X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5068) 5068
Publication (768) 768
Book Review (86) 86
Newsletter (61) 61
Newspaper Article (33) 33
Magazine Article (25) 25
Book Chapter (23) 23
Web Resource (9) 9
Conference Proceeding (4) 4
Government Document (4) 4
Book / eBook (3) 3
Dissertation (3) 3
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3280) 3280
naltrexone (2712) 2712
male (2587) 2587
naltrexone - therapeutic use (2223) 2223
index medicus (1901) 1901
female (1686) 1686
animals (1559) 1559
pharmacology & pharmacy (1521) 1521
narcotic antagonists - therapeutic use (1472) 1472
adult (1439) 1439
naltrexone - pharmacology (1182) 1182
psychiatry (1161) 1161
substance abuse (988) 988
naltrexone - analogs & derivatives (964) 964
rats (899) 899
middle aged (875) 875
neurosciences (868) 868
narcotic antagonists - pharmacology (770) 770
treatment outcome (735) 735
naltrexone - administration & dosage (728) 728
alcoholism - drug therapy (706) 706
pharmacotherapy (633) 633
dose-response relationship, drug (629) 629
alcoholism (571) 571
article (570) 570
double-blind (567) 567
care and treatment (540) 540
dependence (523) 523
narcotic antagonists - administration & dosage (511) 511
dependency (505) 505
morphine (497) 497
double-blind method (494) 494
mice (494) 494
alcohol dependence (458) 458
naloxone (455) 455
opioids (455) 455
alcohol use (454) 454
naltrexone - adverse effects (437) 437
alcohol deterrents - therapeutic use (384) 384
drug therapy (381) 381
adolescent (362) 362
alcohol (361) 361
analysis (354) 354
time factors (334) 334
addiction (331) 331
acamprosate (318) 318
buprenorphine (318) 318
research (318) 318
heroin (316) 316
placebo-controlled trial (316) 316
usa (307) 307
opioid-related disorders - drug therapy (304) 304
clinical neurology (302) 302
drug use (299) 299
narcotics (299) 299
methadone (295) 295
rats, sprague-dawley (289) 289
treatment (289) 289
narcotic antagonists - adverse effects (279) 279
efficacy (273) 273
taurine - analogs & derivatives (270) 270
medicine, general & internal (269) 269
drug abuse (262) 262
aged (257) 257
taurine - therapeutic use (254) 254
therapy (254) 254
young adult (253) 253
morphine - pharmacology (249) 249
substance abuse treatment (247) 247
alcoholism - psychology (246) 246
psychology, clinical (245) 245
methadone - therapeutic use (240) 240
drug therapy, combination (238) 238
clinical trials (237) 237
naloxone - pharmacology (237) 237
ethanol (235) 235
pain (235) 235
randomized controlled-trial (231) 231
withdrawal (221) 221
dosage and administration (218) 218
opioid-related disorders - rehabilitation (214) 214
analgesics, opioid - adverse effects (209) 209
cocaine (204) 204
opioid receptors (204) 204
health aspects (203) 203
combined modality therapy (199) 199
opioid (199) 199
pharmacology/toxicology (195) 195
treatment outcomes (193) 193
disease models, animal (192) 192
buprenorphine - therapeutic use (191) 191
beta-endorphin (189) 189
pharmacology (187) 187
drinking (182) 182
behavior, animal - drug effects (181) 181
detoxification (181) 181
nucleus-accumbens (181) 181
comorbidity (179) 179
drinking of alcoholic beverages (177) 177
alcoholism - rehabilitation (176) 176
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5041) 5041
German (38) 38
Spanish (37) 37
French (35) 35
Russian (14) 14
Italian (11) 11
Norwegian (7) 7
Danish (5) 5
Chinese (4) 4
Japanese (4) 4
Swedish (4) 4
Czech (3) 3
Dutch (3) 3
Finnish (3) 3
Portuguese (3) 3
Hebrew (2) 2
Hungarian (2) 2
Polish (2) 2
Lithuanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Cochrane database of systematic reviews, ISSN 1469-493X, 2015, Volume 5, Issue 5, p. CD003448
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 06/2018, Volume 2018, Issue 6, p. CD006332
Background Opioid-induced bowel dysfunction (OIBD) is characterised by constipation, incomplete evacuation, bloating, and gastric reflux. It is one of the... 
Piperidines [therapeutic use] | EFFICACY | SAFETY | Humans | GUIDELINES | Gastrointestinal Agents [therapeutic use] | Intestinal Diseases [chemically induced; drug therapy] | MEDICINE, GENERAL & INTERNAL | Receptors | SUBCUTANEOUS METHYLNALTREXONE | Constipation [chemically induced; drug therapy] | PARALLEL-GROUP | Nalbuphine [therapeutic use] | mu [antagonists & inhibitors] | Naloxone [therapeutic use] | INDUCED CONSTIPATION | Opioid-Related Disorders [drug therapy] | Naltrexone [analogs & derivatives; therapeutic use] | Opioid | Quaternary Ammonium Compounds [therapeutic use] | PROLONGED-RELEASE TABLETS | Defecation [drug effects] | PAIN | Narcotic Antagonists [therapeutic use] | DOUBLE-BLIND | ADVANCED ILLNESS | Naltrexone - analogs & derivatives | Naltrexone - therapeutic use | Opioid-Related Disorders - drug therapy | Intestinal Diseases - chemically induced | Male | Palliative Care | Neoplasms - complications | Nalbuphine - therapeutic use | Female | Constipation - drug therapy | Oxycodone - adverse effects | Oxycodone - therapeutic use | Defecation - drug effects | Quaternary Ammonium Compounds - therapeutic use | Intestinal Diseases - drug therapy | Narcotic Antagonists - adverse effects | Naloxone - therapeutic use | Receptors, Opioid, mu - antagonists & inhibitors | Constipation - chemically induced | Randomized Controlled Trials as Topic | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Naloxone - adverse effects | Gastrointestinal Agents - therapeutic use | Naltrexone - adverse effects
Journal Article
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 1/2013, Volume 170, Issue 1, pp. 23 - 30
Mood and substance use disorders commonly co-occur, yet there is little evidence-based research to guide the pharmacologic management of these comorbid... 
CONTROLLED CLINICAL-TRIAL | NATIONAL EPIDEMIOLOGIC SURVEY | PSYCHIATRY | COMORBIDITY SURVEY REPLICATION | COCAINE DEPENDENCE | DOUBLE-BLIND | RANDOMIZED-TRIAL | PLACEBO-CONTROLLED TRIAL | MAJOR DEPRESSION | BIPOLAR DISORDER | ALCOHOL DEPENDENCE | Naltrexone - therapeutic use | Substance-Related Disorders - rehabilitation | Mood Disorders - psychology | Antipsychotic Agents - adverse effects | Humans | Sertraline - adverse effects | Alcoholism - diagnosis | Bipolar Disorder - diagnosis | Depressive Disorder, Major - epidemiology | Psychotropic Drugs - therapeutic use | Mood Disorders - epidemiology | Psychotropic Drugs - adverse effects | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Mood Disorders - rehabilitation | Sertraline - therapeutic use | Drug Therapy, Combination | Alcoholism - psychology | Antimanic Agents - adverse effects | Substance-Related Disorders - diagnosis | Bipolar Disorder - rehabilitation | Antimanic Agents - therapeutic use | Double-Blind Method | Comorbidity | Narcotic Antagonists - adverse effects | Depressive Disorder, Major - rehabilitation | Combined Modality Therapy | Controlled Clinical Trials as Topic | Alcoholism - epidemiology | Alcoholism - rehabilitation | Bipolar Disorder - psychology | Antidepressive Agents - therapeutic use | Depressive Disorder, Major - psychology | Narcotic Antagonists - therapeutic use | Mood Disorders - diagnosis | Substance-Related Disorders - psychology | Cognitive Therapy | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Naltrexone - adverse effects | Bipolar Disorder - epidemiology | Diagnosis, Dual (Psychiatry) | Psychological aspects | Drug abuse | Care and treatment | Physiological aspects | Mood (Psychology) | Psychotherapy | Health aspects | Methods
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 7, pp. 1765 - 1779
Journal Article